Blagosklonny MV - Search Results

1

Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.

Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Cell Death Differ. 2006 Sep;13(9):1434-41. doi: 10.1038/sj.cdd.4401812. Epub 2005 Nov 25. Cell Death Differ. 2006. PMID: 16311509

2

Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor.

Demidenko ZN, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Cancer Res. 2004 May 15;64(10):3653-60. doi: 10.1158/0008-5472.CAN-04-0204. Cancer Res. 2004. PMID: 15150125

3

MEK drives cyclin D1 hyperelevation during geroconversion.

Leontieva OV, Demidenko ZN, Blagosklonny MV. Leontieva OV, et al. Among authors: blagosklonny mv. Cell Death Differ. 2013 Sep;20(9):1241-9. doi: 10.1038/cdd.2013.86. Epub 2013 Jul 12. Cell Death Differ. 2013. PMID: 23852369 Free PMC article.

4

Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells.

Blagosklonny MV, Darzynkiewicz Z, Halicka HD, Pozarowski P, Demidenko ZN, Barry JJ, Kamath KR, Herrmann RA. Blagosklonny MV, et al. Cell Cycle. 2004 Aug;3(8):1050-6. Epub 2004 Aug 24. Cell Cycle. 2004. PMID: 15254417

5

Complementation of two mutant p53: implications for loss of heterozygosity in cancer.

Demidenko ZN, Fojo T, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. FEBS Lett. 2005 Apr 11;579(10):2231-5. doi: 10.1016/j.febslet.2005.03.012. FEBS Lett. 2005. PMID: 15811347 Free article.

6

Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin.

Demidenko ZN, An WG, Lee JT, Romanova LY, McCubrey JA, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Cancer Biol Ther. 2005 Apr;4(4):484-90. doi: 10.4161/cbt.4.4.1702. Epub 2005 Apr 5. Cancer Biol Ther. 2005. PMID: 15846067 Free article.

7

Selective killing of adriamycin-resistant (G2 checkpoint-deficient and MRP1-expressing) cancer cells by docetaxel.

Demidenko ZN, Halicka D, Kunicki J, McCubrey JA, Darzynkiewicz Z, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Cancer Res. 2005 May 15;65(10):4401-7. doi: 10.1158/0008-5472.CAN-04-4428. Cancer Res. 2005. PMID: 15899832

8

Cytostatic activity of paclitaxel in coronary artery smooth muscle cells is mediated through transient mitotic arrest followed by permanent post-mitotic arrest: comparison with cancer cells.

Blagosklonny MV, Demidenko ZN, Giovino M, Szynal C, Donskoy E, Herrmann RA, Barry JJ, Whalen AM. Blagosklonny MV, et al. Cell Cycle. 2006 Jul;5(14):1574-9. doi: 10.4161/cc.5.14.3113. Epub 2006 Jul 17. Cell Cycle. 2006. PMID: 16861892

9

p21 (CDKN1A) is a negative regulator of p53 stability.

Broude EV, Demidenko ZN, Vivo C, Swift ME, Davis BM, Blagosklonny MV, Roninson IB. Broude EV, et al. Among authors: blagosklonny mv. Cell Cycle. 2007 Jun 15;6(12):1468-71. Epub 2007 Apr 12. Cell Cycle. 2007. PMID: 17585201

10

Growth stimulation leads to cellular senescence when the cell cycle is blocked.

Demidenko ZN, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Cell Cycle. 2008 Nov 1;7(21):3355-61. doi: 10.4161/cc.7.21.6919. Epub 2008 Nov 12. Cell Cycle. 2008. PMID: 18948731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters